Pfizer Goodwill increased by 0.2% to $71.41B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $68.44B to $71.41B. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 7.5% CAGR.
An increase suggests recent M&A activity, while a significant decrease may signal an impairment charge due to overpayment or declining business prospects.
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Common in large pharmaceutical firms that frequently acquire biotech companies to replenish their drug pipelines.
goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.87B | $49.49B | $49.21B | $50.21B | $49.89B | $49.44B | $51.38B | $51.48B | $51.57B | $51.53B | $67.78B | $69.30B | $68.45B | $68.57B | $68.53B | $68.44B | $69.00B | $69.10B | $71.26B | $71.41B |
| QoQ Change | — | -0.8% | -0.6% | +2.0% | -0.6% | -0.9% | +3.9% | +0.2% | +0.2% | -0.1% | +31.5% | +2.2% | -1.2% | +0.2% | -0.1% | -0.1% | +0.8% | +0.2% | +3.1% | +0.2% |
| YoY Change | — | — | — | — | +0.0% | -0.1% | +4.4% | +2.5% | +3.4% | +4.2% | +31.9% | +34.6% | +32.7% | +33.1% | +1.1% | -1.2% | +0.8% | +0.8% | +4.0% | +4.3% |